Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ LRRIQ4 Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA557782

Catalog No. PIPA557782


Only null left
Add to Cart

Description

Description

Immunogen sequence: MPNLEVLDCR HNLLKQLPDA ICQAQALKEL RLEDNLLTHL PENLDSLVNL KVLTLMDNPM EEPPKEVCAE GNEAIWKYLK ENRNRNIMAT K Highest antigen sequence identity to the following orthologs: Mouse - 77%, Rat - 78%.

LRRIQ4 (Leucine Rich Repeats And IQ Motif Containing 4) is a Protein Coding gene. Diseases associated with LRRIQ4 include Retinitis Pigmentosa 38. An important paralog of this gene is LRRK1.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

LRRIQ4
Polyclonal
Unconjugated
LRRIQ4
leucine rich repeat containing 64; leucine rich repeats and IQ motif containing 4; leucine-rich repeat and IQ domain-containing protein 4; Leucine-rich repeat-containing protein 64; leucine-rich repeats and IQ motif containing 4; LRRC64; LRRIQ4
Rabbit
Antigen affinity chromatography
RUO
344657
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Liquid
Immunohistochemistry (Paraffin)
0.1 mg/mL
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2
A6NIV6
LRRIQ4
Recombinant protein corresponding to Human LRRIQ4. Recombinant protein control fragment (Product #RP-96474).
100 μL
Primary
Human
Antibody
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.